Skip to main content
Megan Rahmlow, MD, Neurology, Brentwood, TN

MeganRRahmlowMD

Neurology Brentwood, TN

Neuroimmunology/Multiple Sclerosis, Neurophysiology

Medical Director, Neurology at Icon plc

Dr. Rahmlow is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rahmlow's full profile

Already have an account?

Summary

  • Medical Director, Neurology, Medical Affairs at Icon. Experience in neuroscience clinical research as an investigator and with a CRO.

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Neuroimmunology & Multiple Sclerosis, 2011 - 2012
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Clinical Neurophysiology, 2010 - 2011
  • Mayo Clinic College of Medicine and Science (Jacksonville)
    Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Neurology, 2007 - 2010
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 2006 - 2007
  • University of Missouri Kansas City School of Medicine
    University of Missouri Kansas City School of MedicineClass of 2006

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2014 - 2026
  • FL State Medical License
    FL State Medical License 2007 - 2015
  • MN State Medical License
    MN State Medical License 2011 - 2013
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • Drug’s Effectiveness for Neurosarcoidosis Studied
    Drug’s Effectiveness for Neurosarcoidosis StudiedNovember 16th, 2017

Professional Memberships